177 related articles for article (PubMed ID: 33621196)
21. TFAP2C-mediated LINC00922 signaling underpins doxorubicin-resistant osteosarcoma.
Gu Z; Zhou Y; Cao C; Wang X; Wu L; Ye Z
Biomed Pharmacother; 2020 Sep; 129():110363. PubMed ID: 32563982
[TBL] [Abstract][Full Text] [Related]
22. CircFAM120B knockdown inhibits osteosarcoma tumorigenesis via the miR-1205/PTBP1 axis.
Li JJ; Xiong MY; Sun TY; Ji CB; Guo RT; Li YW; Guo HY
Aging (Albany NY); 2021 Oct; 13(20):23831-23841. PubMed ID: 34716285
[TBL] [Abstract][Full Text] [Related]
23. MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells.
Minami K; Taniguchi K; Sugito N; Kuranaga Y; Inamoto T; Takahara K; Takai T; Yoshikawa Y; Kiyama S; Akao Y; Azuma H
Oncotarget; 2017 May; 8(20):33064-33077. PubMed ID: 28380435
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
Lin BC; Huang D; Yu CQ; Mou Y; Liu YH; Zhang DW; Shi FJ
Med Sci Monit; 2016 May; 22():1761-5. PubMed ID: 27222034
[TBL] [Abstract][Full Text] [Related]
25. [Sensitivity of doxorubicin-resistant osteosarcoma cells to doxorubicin regulated by long non-coding RNA NR_036444].
Zhu KP; Zhang CL
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):250-255. PubMed ID: 28550663
[No Abstract] [Full Text] [Related]
26. Kaempferol Can Reverse the 5-Fu Resistance of Colorectal Cancer Cells by Inhibiting PKM2-Mediated Glycolysis.
Wu H; Du J; Li C; Li H; Guo H; Li Z
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408903
[TBL] [Abstract][Full Text] [Related]
27. miR-124 promotes neural differentiation in mouse bulge stem cells by repressing Ptbp1 and Sox9.
Mokabber H; Najafzadeh N; Mohammadzadeh Vardin M
J Cell Physiol; 2019 Jun; 234(6):8941-8950. PubMed ID: 30417370
[TBL] [Abstract][Full Text] [Related]
28. MiR-133b inhibits growth of human gastric cancer cells by silencing pyruvate kinase muscle-splicer polypyrimidine tract-binding protein 1.
Sugiyama T; Taniguchi K; Matsuhashi N; Tajirika T; Futamura M; Takai T; Akao Y; Yoshida K
Cancer Sci; 2016 Dec; 107(12):1767-1775. PubMed ID: 27696637
[TBL] [Abstract][Full Text] [Related]
29. A network-based analysis of colon cancer splicing changes reveals a tumorigenesis-favoring regulatory pathway emanating from ELK1.
Hollander D; Donyo M; Atias N; Mekahel K; Melamed Z; Yannai S; Lev-Maor G; Shilo A; Schwartz S; Barshack I; Sharan R; Ast G
Genome Res; 2016 Apr; 26(4):541-53. PubMed ID: 26860615
[TBL] [Abstract][Full Text] [Related]
30. MiR-1180 from bone marrow-derived mesenchymal stem cells induces glycolysis and chemoresistance in ovarian cancer cells by upregulating the Wnt signaling pathway.
Gu ZW; He YF; Wang WJ; Tian Q; Di W
J Zhejiang Univ Sci B; 2019 Mar.; 20(3):219-237. PubMed ID: 30829010
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway.
Zhang Y; Liu Y; Xu X
J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500
[TBL] [Abstract][Full Text] [Related]
32. MiR-326 Inhibits Inflammation and Promotes Autophagy in Silica-Induced Pulmonary Fibrosis through Targeting TNFSF14 and PTBP1.
Xu T; Yan W; Wu Q; Xu Q; Yuan J; Li Y; Li P; Pan H; Ni C
Chem Res Toxicol; 2019 Nov; 32(11):2192-2203. PubMed ID: 31642316
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma.
Sun X; Tian C; Zhang H; Han K; Zhou M; Gan Z; Zhu H; Min D
Biomed Pharmacother; 2020 Aug; 128():110201. PubMed ID: 32460190
[TBL] [Abstract][Full Text] [Related]
34. USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis.
Gao S; Wang Y; Xu Y; Liu L; Liu S
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167011. PubMed ID: 38176460
[TBL] [Abstract][Full Text] [Related]
35. PTBP1 as a Promising Predictor of Poor Prognosis by Regulating Cell Proliferation, Immunosuppression, and Drug Sensitivity in SARC.
Gong H; Jiang A; Jiang R; Wang Y; Zhang D; Wu Z; Xiao J
Oxid Med Cell Longev; 2022; 2022():5687238. PubMed ID: 35651729
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1.
Zhang Y; Duan G; Feng S
Biochem Biophys Res Commun; 2015 Apr; 459(3):367-73. PubMed ID: 25727016
[TBL] [Abstract][Full Text] [Related]
37. NF-κB1, c-Rel, and ELK1 inhibit miR-134 expression leading to TAB1 upregulation in paclitaxel-resistant human ovarian cancer.
Shuang T; Wang M; Zhou Y; Shi C; Wang D
Oncotarget; 2017 Apr; 8(15):24853-24868. PubMed ID: 28206956
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA‑133b alleviates doxorubicin‑induced cardiomyocyte apoptosis and cardiac fibrosis by targeting PTBP1 and TAGLN2.
Li Z; Ye Z; Ma J; Gu Q; Teng J; Gong X
Int J Mol Med; 2021 Jul; 48(1):. PubMed ID: 33982775
[TBL] [Abstract][Full Text] [Related]
39. miR-214 modulates cisplatin sensitivity of osteosarcoma cells through regulation of anaerobic glycolysis.
Song YD; Li DD; Guan Y; Wang YL; Zheng J
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):75-79. PubMed ID: 28980925
[TBL] [Abstract][Full Text] [Related]
40. SNHG16 promotes osteosarcoma progression and enhances cisplatin resistance by sponging miR-16 to upregulate ATG4B expression.
Liu Y; Gu S; Li H; Wang J; Wei C; Liu Q
Biochem Biophys Res Commun; 2019 Oct; 518(1):127-133. PubMed ID: 31427084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
